StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$3.23+0.36 (+12.54%)

Close on Nov 16, 2026Market cap $265.01MP/E –Yield –

Lexeo Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Lexeo Therapeutics's operating margin for the twelve months ending Dec 31, 2022 was -9252.1%. For fiscal 2022 it was -9252.1%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-9252.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2022Sep 30, 2022-3292.3%–

More Lexeo Therapeutics figures

See a number that looks wrong?